A Study of ES104 in Patients With Metastatic Colorectal Cancer

Clinical trial NCT05167448 · UNKNOWN

Trial details

NCT number: NCT05167448
Sponsor: Elpiscience (Suzhou) Biopharma, Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2022-02-25
Primary completion: 2026-05-31
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.